The value of digital health companies grew quickly during the pandemic as healthcare was forced out of the hospital. However, funding has dried up in the last two years.
In 2023, global digital health funding halved for the second year in a row with just $13.2 billion raised in 1,397 deals, according to CB Insights. Deal size was around $4 million and the median digital health deal size trended upward. However, there were only three $100 million-plus deals in the fourth quarter of last year and the digital health unicorns are becoming even less common.
The digital health market has also seen consolidation and partnerships to further integrate into hospitals and health systems. Yahoo Finance compiled the 12 most valuable U.S.-based digital health companies based on current market caps.
1. CVS Health: $97 billion
2. DexCom: $44.5 billion
3. IQVIA: $42.7 billion
4. Veeva Systems: $34.6 billion
5. Simulations Plus: $8.2 billion
6. Doximity: $5.3 billion
7. Health Catalyst: $5.3 billion
8. NeuroPace: $4.1 billion
9. DocGo: $3.6 billion
10. Movano: $3.4 billion
11. Amwell: $3.3 billion
12. 23andMe: $3.2 billion